Appropriate Use of Myocardial Perfusion Imaging in Women

Appropriate Use Lunch Symposium
Appropriate Use of Myocardial Perfusion Imaging in Women
Tuesday, March 28, 2017, 12:15 pm to 1:15 pm
Ballroom 20D, San Diego Convention Center
San Diego, CA


Accreditation and Continuing Education Credit
ASNC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 
ASNC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians can claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
This free activity is intended for practicing internal medicine and primary care physicians as well as mid-level healthcare professionals that refer patients to nuclear cardiology imaging studies.
Overall Goal
This lunch symposium will increase learners’ competence in choosing the appropriate imaging test in women with cardiovascular disease.  Participants will learn the differences in clinical symptons and impact of low pretest probability in women, select appropriate imaging test for advanced diagnostic testing,  evaluate the benefits of myocardial perfusion imaging as well as effective communication between referring physicians and nuclear cardiologists.
Program Agenda
  • Welcome & Introduction
  • Ischemic Heart Disease in Women: Challenges and Opportunities (10 minutes)
  • Choosing the Right Imaging Tests (20 minutes)
  • Challenges in Women with Heart Failure (20 minutes)
  • Summary and Post- Activity Questions
Program Objectives
After participating in this activity, learners should be able to:
  • Describe the differences in clinical symptoms and impact of low pretest probability in women
  • Select the appropriate test and imaging modality for advanced diagnostic testing in women with suspected microvascular disease
  • Evaluate the benefits of myocardial perfusion imaging in women
David Wolinsky, MD, FASNC
Cleveland Clinic Florida
Weston, Fl
Andria Medina, MD, PhD.
Department of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Lawrence M. Phillips, MD
Division of Cardiology
New York University Langone Medical Center
New York, NY?

Statement of Need
Cardiovascular disease is the number one cause of death in women ≥ 65 years of age. [Mozaffarian 2016] Awareness among women of this risk is low. Among healthcare providers there is a significant knowledge gap regarding the existence of sex differences in cardiovascular disease and an understanding of the basic mechanisms and relevant pathophysiology to explain the differences. [Bairey Merz 2010] The gender gap in mortality remains a concern for women especially the increasing rate in the 35-44 year old age group, and in African American women in whom the incidence of myocardial infarction is higher in all age categories and death rates is 41% higher than that of white women. [Mozaffarian 2016] A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of men and women. These studies provide highly sensitive and specific information on the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who benefit from revascularization. As a result of the recognized clinical value and cost-effectiveness of these studies, they have been incorporated into many American College of Physicians/American College Cardiology/American Heart Association (AHA)/ASNC clinical management guidelines.

Acknowledgement of Commercial Support
This activity is supported by an educational grant from Astellas Pharma Global Development, Inc.
This event is not part of the official Internal Medicine Meeting 2017 Education Program.